{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:30:02Z","timestamp":1789435802079,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1774,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.bbmt.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T04:18:24Z","timestamp":1263529104000},"page":"832-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["A Prospective Study of Iron Overload Management in Allogeneic Hematopoietic Cell Transplantation Survivors"],"prefix":"10.1016","volume":"16","author":[{"given":"Navneet S.","family":"Majhail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.01.004_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbmt.2008.04.009","article-title":"High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors","volume":"14","author":"Majhail","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/bmt.2008.99","article-title":"Iron overload in hematopoietic cell transplantation","volume":"41","author":"Majhail","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.004_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3324\/haematol.11063","article-title":"Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long-term survivors after allogeneic hematopoietic stem cell transplantation (HSCT)","volume":"92","author":"Rose","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1701885","article-title":"Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis","volume":"24","author":"Maertens","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.004_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/10245332.1999.11746478","article-title":"Serum ferritin as risk factor for veno-occlusive disease of the liver: prospective cohort study","volume":"4","author":"Morado","year":"2000","journal-title":"Hematology"},{"key":"10.1016\/j.bbmt.2010.01.004_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood.V100.1.17","article-title":"Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation","volume":"100","author":"Angelucci","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/0140-6736(93)92753-G","article-title":"Fate of iron stores in thalassaemia after bone marrow transplantation","volume":"342","author":"Lucarelli","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.004_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.2006.06455.x","article-title":"A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease","volume":"136","author":"Vichinsky","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.01.004_bib10","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","article-title":"A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with {beta}-thalassemia","volume":"107","author":"Cappellini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/mrm.20510","article-title":"Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry","volume":"54","author":"Carneiro","year":"2005","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.bbmt.2010.01.004_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","article-title":"Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance","volume":"105","author":"St Pierre","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.004_bib13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2\u2217 mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.V90.3.994","article-title":"Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients","volume":"90","author":"Angelucci","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-136-9-200205070-00009","article-title":"Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation","volume":"136","author":"Muretto","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2010.01.004_bib16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbmt.2006.01.004","article-title":"Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Kamble","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.004_bib17","first-page":"63","article-title":"Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation","volume":"17","author":"McKay","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.004_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0609.2007.00985.x","article-title":"Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-year prospective study","volume":"80","author":"Porter","year":"2008","journal-title":"Eur J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:37:14Z","timestamp":1761057434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1083879110000091"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.01.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective Study of Iron Overload Management in Allogeneic Hematopoietic Cell Transplantation Survivors","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}